Αποτελέσματα Αναζήτησης
11 Ιαν 2024 · Gene vaccines work by harnessing advances in biochemistry, molecular biology, genetics and chemistry to deliver selected portions of the deoxyribonucleic acid (DNA), or messenger ribonucleic acid (mRNA), of the pathogen of interest.
1 Ιουλ 2024 · A direct comparison between the trials of DNA and mRNA vaccines clearly points out that mRNA is currently more favorable than DNA – almost all nucleic acid vaccine trials that are in phase 3 are based on mRNA instead of DNA, which indicates better results from earlier phase mRNA trials.
23 Δεκ 2020 · RNA vaccines encode the antigen of interest in messenger RNA (mRNA) or self-amplifying RNA (saRNA) – molecular templates used by cellular factories to produce proteins. Because of its transitory nature, there is zero risk of it integrating with our own genetic material.
4 Οκτ 2024 · First, the flexibility of antigen design (the mRNA sequence can be rapidly modified) makes mRNA vaccines ideal to target rapidly evolving pathogens such as influenza virus and severe acute...
DNA and messenger RNA (mRNA) vaccines do not require the use of a live infectious agent such as a bacteria or virus, have been shown to stimulate disease-fighting responses in T-cells and B-cells, and are more stable, less costly and easier to produce in mass quantities than traditional vaccines.
25 Αυγ 2021 · Depending on the challenges, mRNA vaccines encoding conformation-specific proteins, conserved regions of antigens or monoclonal antibodies can be safely delivered to healthy adults, children ...
1 Ιουλ 2024 · Nucleic acid technology has revolutionized vaccine development, enabling rapid design and production of RNA and DNA vaccines for prevention and treatment of diseases. The successful deployment of mRNA and plasmid DNA vaccines against COVID-19 has further validated the technology.
